Platinum sulfide protein nanoparticle having near-infrared photothermal effect and multimodal imaging function, preparation method therefor and application thereof

US11364312B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11364312-B2
Application numberUS-202117169455-A
CountryUS
Kind codeB2
Filing dateFeb 6, 2021
Priority dateAug 7, 2018
Publication dateJun 21, 2022
Grant dateJun 21, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A platinum sulfide protein nanoparticle having near-infrared photothermal effect and multi-modal imaging function, a preparation method therefor and an application thereof. The platinum sulfide nanoparticle having near-infrared photothermal effect and multi-modal imaging function is prepared in aqueous phase by means of formulation screening and process limitation. The nanoparticle has an ultra-small particle size and good stability as well as tumor targeting and photothermal effects and integrates functions of near-infrared imaging, CT imaging, and thermal imaging, so as to achieve high sensitivity, high resolution, and precise positioning of tumors, and to produce high-efficiency photothermal effects under the excitation of near-infrared light to kill tumor cells by thermal ablation, thereby achieving the purpose of efficient, safe, visual, and accurate treatment of tumors. The nanoparticle has the potential for further development and clinical application.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of preparing a platinum sulfide protein nanoparticle with near-infrared photothermal effect and multi-modal imaging function, consisting of the following steps: mixing a platinum dichloride solution with a protein solution, adding sodium sulphide solution, reacting to form a mixture, and dialyzing and ultrafiltrating the mixture to obtain the platinum sulfide protein nanoparticle with near-infrared photothermal effect and multi-modal imaging function, wherein a concentration of the platinum dichloride solution is 2 to 8 mmol/L; a concentration of the protein solution is 1 to 9 mg/mL; a concentration of the sodium sulphide solution is 1-50 mmol/L; a volume ratio of the platinum dichloride solution, the protein solution, and the sodium sulfide solution is 1:0.2:0.05; wherein a reaction temperature is 0 to 55° C., a reaction time is 0 to 5 h; wherein a cut-off molecular weight for dialyzing is 3500 kD, dialyzing dialysis time is 1 to 24 h, a receiving medium for dialyzing is deionized water, and the receiving medium is changed 6 to 8 times; and wherein a cut-off molecular weight for ultrafiltrating is 100 kD, a rotation speed of ultrafiltrating is 1500 to 4000 r/min, and a number of ultrafiltrating is at least 20 times. 2. A method of preparing a reagent with near-infrared photothermal effect and multi-modal imaging function, consisting of the following steps: mixing a platinum dichloride solution with a protein solution, adding a sodium sulphide solution, reacting to form a mixture; and dialyzing and ultrafiltrating the mixture to obtain a platinum sulfide protein nanoparticle with near-infrared photothermal effect and multi-modal imaging function, and dispersing the platinum sulfide protein nanoparticle with deionized water to obtain the reagent with near-infrared photothermal effect and multi-modal imaging function, wherein a concentration of the platinum dichloride solution is 2 to 8 mmol/L; a concentration of the protein solution is 1 to 9 mg/mL; a concentration of the sodium sulphide solution is 1-50 mmol/L; a volume ratio of the platinum dichloride solution, the protein solution, and the sodium sulfide solution is 1:0.2:0.05; wherein a reaction temperature is 0 to 55° C., a reaction time is 0 to 5 h; wherein a cut-off molecular weight for dialyzing is 3500 kD, dialyzing dialysis time is 1 to 24 h, a receiving medium for dialyzing is deionized water, and the receiving medium is changed 6 to 8 times; and wherein a cut-off molecular weight for ultrafiltrating is 100 kD, a rotation speed of ultrafiltrating is 1500 to 4000 r/min, and a number of ultrafiltrating is at least 20 times. 3. The method according to claim 1 , wherein a diameter of the platinum sulfide protein nanoparticle with near-infrared photothermal effect and multi-modal imaging function is 1 to 5 nm. 4. The method according to claim 3 , wherein the platinum sulfide protein nanoparticle with near-infrared photothermal effect and multi-modal imaging function consists of a platinum sulfide protein nanoparticle scaffold and a the platinum sulfide core.

Assignees

Inventors

Classifications

  • Proteins, e.g. albumin, gelatin · CPC title

  • Processes · CPC title

  • Inorganic compounds · CPC title

  • Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy · CPC title

  • X-ray contrast preparations · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11364312B2 cover?
A platinum sulfide protein nanoparticle having near-infrared photothermal effect and multi-modal imaging function, a preparation method therefor and an application thereof. The platinum sulfide nanoparticle having near-infrared photothermal effect and multi-modal imaging function is prepared in aqueous phase by means of formulation screening and process limitation. The nanoparticle has an ultra…
Who is the assignee on this patent?
Univ Soochow
What technology area does this patent fall under?
Primary CPC classification A61K41/0052. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).